Cancer Research Cell Death Mechanisms and Cancer Therapy  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Psyrri, A.
Right arrow Articles by DiMaio, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Psyrri, A.
Right arrow Articles by DiMaio, D.
[Cancer Research 64, 3079-3086, May 1, 2004]
© 2004 American Association for Cancer Research


Regular Articles

Role of the Retinoblastoma Pathway in Senescence Triggered by Repression of the Human Papillomavirus E7 Protein in Cervical Carcinoma Cells

Amanda Psyrri1, Rosa Anna DeFilippis2, Anne P. B. Edwards2, Kristin E. Yates2, Laertes Manuelidis2 and Daniel DiMaio2

1 Section of Medical Oncology and 2 Department of Genetics, Yale University School of Medicine, New Haven, Connecticut

Repression of the endogenous human papillomavirus (HPV) type 18 E7 gene in HeLa cervical carcinoma cells by the bovine papillomavirus E2 transcription factor activates the retinoblastoma (Rb) pathway and induces cells to undergo senescence. To determine whether activation of the Rb pathway is responsible for senescence in response to HPV18 E7 repression, we tested the ability of wild-type and mutant E7 proteins to affect the activity of the Rb pathway and to modulate senescence in these cells. Enforced expression of the wild-type HPV16 E7 protein prevented Rb activation in response to E2 expression and impaired senescence. Importantly, there was an absolute correlation between the ability of mutant E7 proteins to inactivate the Rb pathway and to inhibit senescence in HeLa cells. Similar results were obtained in HT-3 cervical carcinoma cells. These results provide strong genetic evidence that activation of the Rb pathway is required for senescence in response to E7 repression. Hence, continuous neutralization of the Rb pathway by the E7 protein is required to maintain the proliferation of cervical carcinoma cells. Similarly, our results indicate that activation of the Rb pathway can prevent apoptosis induced by repression of the HPV18 E6 gene in HeLa cells.




This article has been cited by other articles:


Home page
J. Virol.Home page
E. C. Goodwin, W. J. Atwood, and D. DiMaio
High-Throughput Cell-Based Screen for Chemicals That Inhibit Infection by Simian Virus 40 and Human Polyomaviruses
J. Virol., June 1, 2009; 83(11): 5630 - 5639.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
T. Rampias, C. Sasaki, P. Weinberger, and A. Psyrri
E6 and E7 Gene Silencing and Transformed Phenotype of Human Papillomavirus 16-Positive Oropharyngeal Cancer Cells
J Natl Cancer Inst, March 18, 2009; 101(6): 412 - 423.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. E. McLaughlin-Drubin, K.-W. Huh, and K. Munger
Human Papillomavirus Type 16 E7 Oncoprotein Associates with E2F6
J. Virol., September 1, 2008; 82(17): 8695 - 8705.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
J. B. Liao, J. Publicover, J. K. Rose, and D. DiMaio
Single-Dose, Therapeutic Vaccination of Mice with Vesicular Stomatitis Virus Expressing Human Papillomavirus Type 16 E7 Protein
Clin. Vaccine Immunol., May 1, 2008; 15(5): 817 - 824.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. A. Darnell, W. A. Schroder, T. M. Antalis, E. Lambley, L. Major, J. Gardner, G. Birrell, A. Cid-Arregui, and A. Suhrbier
Human Papillomavirus E7 Requires the Protease Calpain to Degrade the Retinoblastoma Protein
J. Biol. Chem., December 28, 2007; 282(52): 37492 - 37500.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. L. Nguyen, R. M. Kraft, M. Aubert, E. Goodwin, D. DiMaio, and J. A. Blaho
p53 and hTERT Determine Sensitivity to Viral Apoptosis
J. Virol., December 1, 2007; 81(23): 12985 - 12995.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. Johung, E. C. Goodwin, and D. DiMaio
Human Papillomavirus E7 Repression in Cervical Carcinoma Cells Initiates a Transcriptional Cascade Driven by the Retinoblastoma Family, Resulting in Senescence
J. Virol., March 1, 2007; 81(5): 2102 - 2116.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
O. Binda, J.-S. Roy, and P. E. Branton
RBP1 Family Proteins Exhibit SUMOylation-Dependent Transcriptional Repression and Induce Cell Growth Inhibition Reminiscent of Senescence.
Mol. Cell. Biol., March 1, 2006; 26(5): 1917 - 1931.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
P. M. Weinberger, Z. Yu, B. G. Haffty, D. Kowalski, M. Harigopal, J. Brandsma, C. Sasaki, J. Joe, R. L. Camp, D. L. Rimm, et al.
Molecular Classification Identifies a Subset of Human Papillomavirus-Associated Oropharyngeal Cancers With Favorable Prognosis
J. Clin. Oncol., February 10, 2006; 24(5): 736 - 747.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. N. Putral, M. J. Bywater, W. Gu, N. A. Saunders, B. G. Gabrielli, G. R. Leggatt, and N. A. J. McMillan
RNA Interference against Human Papillomavirus Oncogenes in Cervical Cancer Cells Results in Increased Sensitivity to Cisplatin
Mol. Pharmacol., November 1, 2005; 68(5): 1311 - 1319.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. Behrend, A. Mohr, T. Dick, and R. M. Zwacka
Manganese Superoxide Dismutase Induces p53-Dependent Senescence in Colorectal Cancer Cells
Mol. Cell. Biol., September 1, 2005; 25(17): 7758 - 7769.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K.-W. Huh, J. DeMasi, H. Ogawa, Y. Nakatani, P. M. Howley, and K. Munger
Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600
PNAS, August 9, 2005; 102(32): 11492 - 11497.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. A. Darnell, T. M. Antalis, B. R. Rose, and A. Suhrbier
Silencing of Integrated Human Papillomavirus Type 18 Oncogene Transcription in Cells Expressing SerpinB2
J. Virol., April 1, 2005; 79(7): 4246 - 4256.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
K. Maehara, K. Yamakoshi, N. Ohtani, Y. Kubo, A. Takahashi, S. Arase, N. Jones, and E. Hara
Reduction of total E2F/DP activity induces senescence-like cell cycle arrest in cancer cells lacking functional pRB and p53
J. Cell Biol., February 14, 2005; 168(4): 553 - 560.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
O. Bischof, K. Nacerddine, and A. Dejean
Human Papillomavirus Oncoprotein E7 Targets the Promyelocytic Leukemia Protein and Circumvents Cellular Senescence via the Rb and p53 Tumor Suppressor Pathways
Mol. Cell. Biol., February 1, 2005; 25(3): 1013 - 1024.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Z. Yu, P. M. Weinberger, B. G. Haffty, C. Sasaki, C. Zerillo, J. Joe, D. Kowalski, J. Dziura, R. L. Camp, D. L. Rimm, et al.
Cyclin D1 Is a Valuable Prognostic Marker in Oropharyngeal Squamous Cell Carcinoma
Clin. Cancer Res., February 1, 2005; 11(3): 1160 - 1166.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.